Phagos focuses on addressing antimicrobial resistance through the development of bacteriophage-based treatments. The company offers customizable drugs that use the evolutionary potential of bacteriophages to target and eliminate resistant bacteria. Serving the healthcare sector, Phagos aims to provide sustainable, precision alternatives to traditional antibiotics for life-threatening infections.